Ifp Advisors, Inc Viking Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 42,124 shares of VKTX stock, worth $1.33 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

42,124

Previous 20,299 107.52%

Holding current value

$1.33 Million

Previous $1.29 Million 31.91%

% of portfolio

0.06%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$38.28 - $78.03 $835,461 - $1.7 Million	21,825 Added 107.52%	42,124 $1.7 Million
Q3 2024 Feb 04, 2025	BUY	$49.84 - $70.47 $985,286 - $1.39 Million	19,769 Added 3730.0%	20,299 $1.29 Million
Q2 2024 Jul 30, 2024	BUY	$47.39 - $80.2 $25,116 - $42,506	530 New	530 $28,000
Q2 2022 Sep 06, 2022	BUY	$2.11 - $3.15 $877 - $1,310	416 New	416 $4,000
Q2 2022 Aug 12, 2022	SELL	$2.11 - $3.15 $877 - $1,310	-416 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$3.0 - $4.88 $1,200 - $1,952	400 Added 2500.0%	416 $1,000
Q4 2021 Jan 12, 2022	SELL	$4.6 - $6.72 $13,284 - $19,407	-2,888 Reduced 99.45%	16 $1,000
Q3 2021 Oct 06, 2021	BUY	$5.58 - $7.04 $167 - $211	30 Added 1.04%	2,904 $32,000
Q2 2021 Jul 13, 2021	SELL	$5.19 - $6.73 $93 - $121	-18 Reduced 0.62%	2,874 $15,000
Q1 2021 Apr 30, 2021	BUY	$5.74 - $9.67 $2,186 - $3,684	381 Added 15.17%	2,892 $16,000
Q4 2020 Jan 25, 2021	SELL	$5.3 - $6.71 $190 - $241	-36 Reduced 1.41%	2,511 $13,000
Q1 2020 May 12, 2020	SELL	$3.45 - $7.95 $2,190 - $5,048	-635 Reduced 19.96%	2,547 $12,000
Q4 2019 Jan 17, 2020	BUY	$6.38 - $8.73 $338 - $462	53 Added 1.69%	3,182 $27,000
Q3 2019 Nov 07, 2019	BUY	$6.55 - $8.6 $16,564 - $21,749	2,529 Added 421.5%	3,129 $21,000
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $19,389 - $25,426	-2,558 Reduced 81.0%	600 $6,000
Q4 2018 Jan 23, 2019	BUY	$7.16 - $16.21 $18,315 - $41,465	2,558 Added 426.33%	3,158 $24,000
Q3 2018 Oct 25, 2018	SELL	$9.7 - $19.65 $38,800 - $78,600	-4,000 Reduced 86.96%	600 $0
Q2 2018 Aug 07, 2018	BUY	$3.88 - $12.74 $14,453 - $47,456	3,725 Added 425.71%	4,600 $0
Q1 2018 May 09, 2018	BUY	$4.11 - $6.93 $1,130 - $1,905	275 Added 45.83%	875 $0
Q1 2016 Jun 03, 2019	BUY	N/A	600	600 $6,000

Others Institutions Holding VKTX

# of Institutions

465

Shares Held

63.9M

Call Options Held

5.76M

Put Options Held

3.4M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.42B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account